S. Du

发表

Measurement of dabigatran, rivaroxaban and apixaban in samples of plasma, serum and urine, under real life conditions. An international study

C. Weiss, M. Wehling, J. Harenberg, 2016, Clinical chemistry and laboratory medicine.

A heparin derivatives library constructed by chemical modification and enzymatic depolymerization for exploitation of non-anticoagulant functions.

Zhenqing Zhang, X. Xing, Chong Zhang, 2020, Carbohydrate polymers.

Discovery of enzymatically depolymerized heparins capable of treating Bleomycin-induced pulmonary injury and fibrosis in mice.

X. Xing, Chong Zhang, Wenming Zhu, 2017, Carbohydrate polymers.

Anticoagulation in patients with impaired renal function and with haemodialysis Anticoagulant effects , efficacy , safety , therapeutic options

C. Weiss, M. Wehling, J. Harenberg, 2014 .

Performance Characteristics of DOAC Dipstick in Determining Direct Oral Anticoagulants in Urine

S. Hetjens, C. Weiss, J. Harenberg, 2021, Clinical and applied thrombosis/hemostasis : official journal of the International Academy of Clinical and Applied Thrombosis/Hemostasis.

Measurement of Non–Vitamin K Antagonist Oral Anticoagulants in Patient Plasma Using Heptest-STAT Coagulation Method

C. Weiss, M. Wehling, J. Harenberg, 2015, Therapeutic drug monitoring.

Patients' Serum and Urine as Easily Accessible Samples for the Measurement of Non–Vitamin K Antagonist Oral Anticoagulants

C. Weiss, M. Wehling, J. Harenberg, 2015, Seminars in Thrombosis & Hemostasis.

Report of the Subcommittee on Control of Anticoagulation on the determination of the anticoagulant effects of apixaban: communication from the SSC of the ISTH

C. Weiss, D. Hoppensteadt, J. Harenberg, 2014, Journal of thrombosis and haemostasis : JTH.

Anticoagulation in patients with impaired renal function and with haemodialysis. Anticoagulant effects, efficacy, safety, therapeutic options.

C. Weiss, M. Wehling, J. Harenberg, 2015, Hamostaseologie.

Concept of a point of care test to detect new oral anticoagulants in urine samples

C. Weiss, J. Harenberg, R. Krämer, 2013, Thrombosis Journal.

The influence of fetal gender and maternal characteristics on fetal cell-free DNA in maternal plasma.

S. Du, Qiongzhen Zhao, JiaNaGuLi HuoJiaBieKe, 2019, Journal of gynecology obstetrics and human reproduction.

Therapeutic Effect and Cost-Benefit Analysis of Three Different Nutritional Schemes for Esophageal Cancer Patients in the Early Post-operative Period

Jie He, Qian Bai, Chen Huang, 2021, Frontiers in Nutrition.

Measurement of rivaroxaban and apixaban in serum samples of patients

C. Weiss, M. Wehling, G. Lip, 2014, European journal of clinical investigation.

Determination of Direct Oral Anticoagulants from Human Serum Samples

C. Weiss, J. Harenberg, A. Schulze, 2013, Seminars in Thrombosis & Hemostasis.

Novel Methods for Assessing Oral Direct Factor Xa and Thrombin Inhibitors: Use of Point-of-Care Testing and Urine Samples

C. Weiss, J. Harenberg, A. Schulze, 2012, Seminars in Thrombosis & Hemostasis.

Non-anticoagulant effects of low molecular weight heparins in inflammatory disorders: A review.

X. Xing, Chong Zhang, Wenming Zhu, 2017, Carbohydrate polymers.

Determination of dabigatran in plasma, serum, and urine samples: comparison of six methods

C. Weiss, M. Wehling, J. Harenberg, 2015, Clinical chemistry and laboratory medicine.

Effects of Enzymatically Depolymerized Low Molecular Weight Heparins on CCl4-Induced Liver Fibrosis

X. Xing, Chong Zhang, Wenming Zhu, 2017, Front. Pharmacol..

Anticoagulation in patients with impaired renal function and with haemodialysis

B. Krämer, R. Krämer, S. Du, 2014, Hämostaseologie.

Measurement of Non–Vitamin K Antagonist Oral Anticoagulants in Patient Plasma Using Heptest-STAT Coagulation Method

C. Weiss, M. Wehling, J. Harenberg, 2015, Therapeutic drug monitoring.